Low Plasma Ionized Calcium Is Associated With Increased Mortality: A Population-based Study of 106 768 Individuals

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Low Plasma Ionized Calcium Is Associated With Increased Mortality : A Population-based Study of 106 768 Individuals. / Kobylecki, Camilla J.; Nordestgaard, Børge G.; Afzal, Shoaib.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 107, No. 7, 2022, p. E3039-E3047.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kobylecki, CJ, Nordestgaard, BG & Afzal, S 2022, 'Low Plasma Ionized Calcium Is Associated With Increased Mortality: A Population-based Study of 106 768 Individuals', Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 7, pp. E3039-E3047. https://doi.org/10.1210/clinem/dgac146

APA

Kobylecki, C. J., Nordestgaard, B. G., & Afzal, S. (2022). Low Plasma Ionized Calcium Is Associated With Increased Mortality: A Population-based Study of 106 768 Individuals. Journal of Clinical Endocrinology and Metabolism, 107(7), E3039-E3047. https://doi.org/10.1210/clinem/dgac146

Vancouver

Kobylecki CJ, Nordestgaard BG, Afzal S. Low Plasma Ionized Calcium Is Associated With Increased Mortality: A Population-based Study of 106 768 Individuals. Journal of Clinical Endocrinology and Metabolism. 2022;107(7):E3039-E3047. https://doi.org/10.1210/clinem/dgac146

Author

Kobylecki, Camilla J. ; Nordestgaard, Børge G. ; Afzal, Shoaib. / Low Plasma Ionized Calcium Is Associated With Increased Mortality : A Population-based Study of 106 768 Individuals. In: Journal of Clinical Endocrinology and Metabolism. 2022 ; Vol. 107, No. 7. pp. E3039-E3047.

Bibtex

@article{07e96c9fa5304b319da3f831c7750e8c,
title = "Low Plasma Ionized Calcium Is Associated With Increased Mortality: A Population-based Study of 106 768 Individuals",
abstract = "Context: Low circulating total calcium or albumin-adjusted calcium has been associated with higher mortality, especially in hospital settings; however, these measures tend to misclassify patients with derangements in calcium homeostasis. Objective: As the association of the biologically active ionized calcium with mortality is poorly elucidated, we tested the hypothesis that low plasma ionized calcium is associated with higher risk of all-cause and cause-specific mortality in the general population. Methods: We included 106768 individuals from the Copenhagen General Population Study. Information on all-cause and cause-specific mortality was from registries and risks were calculated using Cox regression and competing-risks regression by the STATA command stcompet. Results: During a median follow-up period of 9.2 years, 11269 individuals died. Each 0.1 mmol/L lower plasma ionized calcium below the median of 1.21 mmol/L was associated with a multivariable adjusted hazard ratio of 1.23 (95% CI, 1.10-1.38) for all-cause mortality. Corresponding hazard ratios for cancer and other mortality were 1.29 (1.06-1.57) and 1.24 (1.01-1.53), respectively. In contrast, for cardiovascular mortality, only high plasma ionized calcium was associated with mortality with a hazard ratio of 1.17 (1.02-1.35) per 0.1 mmol/L higher plasma ionized calcium above the median. We found no interactions between plasma ionized calcium and preexisting cardiovascular or renal disease on all-cause mortality. Conclusion: In the general population, low plasma ionized calcium was associated with increased all-cause, cancer, and other mortality, while high levels were associated with increased cardiovascular mortality.",
keywords = "albumin-adjusted calcium, all-cause mortality, cause-specific mortality, ionized calcium, total calcium",
author = "Kobylecki, {Camilla J.} and Nordestgaard, {B{\o}rge G.} and Shoaib Afzal",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.",
year = "2022",
doi = "10.1210/clinem/dgac146",
language = "English",
volume = "107",
pages = "E3039--E3047",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0013-7227",
publisher = "Oxford University Press",
number = "7",

}

RIS

TY - JOUR

T1 - Low Plasma Ionized Calcium Is Associated With Increased Mortality

T2 - A Population-based Study of 106 768 Individuals

AU - Kobylecki, Camilla J.

AU - Nordestgaard, Børge G.

AU - Afzal, Shoaib

N1 - Publisher Copyright: © 2022 The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.

PY - 2022

Y1 - 2022

N2 - Context: Low circulating total calcium or albumin-adjusted calcium has been associated with higher mortality, especially in hospital settings; however, these measures tend to misclassify patients with derangements in calcium homeostasis. Objective: As the association of the biologically active ionized calcium with mortality is poorly elucidated, we tested the hypothesis that low plasma ionized calcium is associated with higher risk of all-cause and cause-specific mortality in the general population. Methods: We included 106768 individuals from the Copenhagen General Population Study. Information on all-cause and cause-specific mortality was from registries and risks were calculated using Cox regression and competing-risks regression by the STATA command stcompet. Results: During a median follow-up period of 9.2 years, 11269 individuals died. Each 0.1 mmol/L lower plasma ionized calcium below the median of 1.21 mmol/L was associated with a multivariable adjusted hazard ratio of 1.23 (95% CI, 1.10-1.38) for all-cause mortality. Corresponding hazard ratios for cancer and other mortality were 1.29 (1.06-1.57) and 1.24 (1.01-1.53), respectively. In contrast, for cardiovascular mortality, only high plasma ionized calcium was associated with mortality with a hazard ratio of 1.17 (1.02-1.35) per 0.1 mmol/L higher plasma ionized calcium above the median. We found no interactions between plasma ionized calcium and preexisting cardiovascular or renal disease on all-cause mortality. Conclusion: In the general population, low plasma ionized calcium was associated with increased all-cause, cancer, and other mortality, while high levels were associated with increased cardiovascular mortality.

AB - Context: Low circulating total calcium or albumin-adjusted calcium has been associated with higher mortality, especially in hospital settings; however, these measures tend to misclassify patients with derangements in calcium homeostasis. Objective: As the association of the biologically active ionized calcium with mortality is poorly elucidated, we tested the hypothesis that low plasma ionized calcium is associated with higher risk of all-cause and cause-specific mortality in the general population. Methods: We included 106768 individuals from the Copenhagen General Population Study. Information on all-cause and cause-specific mortality was from registries and risks were calculated using Cox regression and competing-risks regression by the STATA command stcompet. Results: During a median follow-up period of 9.2 years, 11269 individuals died. Each 0.1 mmol/L lower plasma ionized calcium below the median of 1.21 mmol/L was associated with a multivariable adjusted hazard ratio of 1.23 (95% CI, 1.10-1.38) for all-cause mortality. Corresponding hazard ratios for cancer and other mortality were 1.29 (1.06-1.57) and 1.24 (1.01-1.53), respectively. In contrast, for cardiovascular mortality, only high plasma ionized calcium was associated with mortality with a hazard ratio of 1.17 (1.02-1.35) per 0.1 mmol/L higher plasma ionized calcium above the median. We found no interactions between plasma ionized calcium and preexisting cardiovascular or renal disease on all-cause mortality. Conclusion: In the general population, low plasma ionized calcium was associated with increased all-cause, cancer, and other mortality, while high levels were associated with increased cardiovascular mortality.

KW - albumin-adjusted calcium

KW - all-cause mortality

KW - cause-specific mortality

KW - ionized calcium

KW - total calcium

U2 - 10.1210/clinem/dgac146

DO - 10.1210/clinem/dgac146

M3 - Journal article

C2 - 35276011

AN - SCOPUS:85132455556

VL - 107

SP - E3039-E3047

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0013-7227

IS - 7

ER -

ID: 321709164